ED
ORTX

Exane Derivatives’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Exane Derivatives’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-431
Closed -$66.4K – 742
2019
Q4 		$66.4K Hold
431
– – 0.01% 344
2019
Q3 		$51.2K Hold
431
– – 0.01% 368
2019
Q2 		$60.3K Buy
+431
New +$75.7K 0.01% 374

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Exane Derivatives's ORTX Position: Q1 2020 in Review

Exane Derivatives sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2020, closing a stake of 431 shares — an estimated $66.4K sold.

Exane Derivatives first reported a position in ORTX in Q2 2019 and held it in 3 quarters. The position peaked at $66.4K in Q4 2019. 74 funds tracked by Wall St. Rank hold ORTX as of Q1 2020.

  • Exane Derivatives reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2020 after selling out during the quarter.
  • Exane Derivatives sold 431 Orchard Therapeutics plc American Depositary Shares shares in Q1 2020, an estimated $66.4K.
  • Exane Derivatives first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2019 and held it in 3 quarters.
  • Exane Derivatives's Orchard Therapeutics plc American Depositary Shares position peaked at $66.4K in Q4 2019.
  • 74 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2020.

Based on Exane Derivatives's 13F filing for Q1 2020, filed 17 Apr 2020.